These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27167507)

  • 41. New ultraviolet C light-based method for pathogen inactivation of red blood cell units.
    Handke W; Gravemann U; Müller TH; Wagner FF; Schulze TJ; Seltsam A
    Transfusion; 2022 Nov; 62(11):2314-2323. PubMed ID: 36087025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow path system of ultraviolet C irradiation from xenon flash to reduce bacteria survival in platelet products containing a platelet additive solution.
    Abe H; Endo K; Shiba M; Niibe Y; Miyata S; Satake M
    Transfusion; 2020 May; 60(5):1050-1059. PubMed ID: 32187695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
    Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
    Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system.
    Johnson L; Loh YS; Kwok M; Marks DC
    Transfus Med; 2013 Apr; 23(2):121-9. PubMed ID: 23480103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
    Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
    Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
    Ohlsson S; Diedrich B; Uhlin M; Sandgren P
    Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.
    Brouard N; Pissenem-Rudwill F; Mouriaux C; Haas D; Galvanin A; Kientz D; Mangin PH; Isola H; Hechler B
    Transfusion; 2023 Oct; 63(10):1937-1950. PubMed ID: 37615493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultraviolet C light efficiently inactivates nonenveloped hepatitis A virus and feline calicivirus in platelet concentrates.
    Gravemann U; Handke W; Lambrecht B; Schmidt JP; Müller TH; Seltsam A
    Transfusion; 2018 Nov; 58(11):2669-2674. PubMed ID: 30267410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling.
    Reid S; Johnson L; Woodland N; Marks DC
    Transfusion; 2012 Oct; 52(10):2094-103. PubMed ID: 22320126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.
    Seltsam A; Müller TH
    Transfus Med Hemother; 2011; 38(1):43-54. PubMed ID: 21779205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additive solutions differentially affect metabolic and functional parameters of platelet concentrates.
    Leitner GC; List J; Horvath M; Eichelberger B; Panzer S; Jilma-Stohlawetz P
    Vox Sang; 2016 Jan; 110(1):20-6. PubMed ID: 26274931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.
    Arnason NA; Johannson F; Landrö R; Hardarsson B; Irsch J; Gudmundsson S; Rolfsson O; Sigurjonsson OE
    Transfusion; 2019 Dec; 59(12):3727-3735. PubMed ID: 31674051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.
    Lin L; Cook DN; Wiesehahn GP; Alfonso R; Behrman B; Cimino GD; Corten L; Damonte PB; Dikeman R; Dupuis K; Fang YM; Hanson CV; Hearst JE; Lin CY; Londe HF; Metchette K; Nerio AT; Pu JT; Reames AA; Rheinschmidt M; Tessman J; Isaacs ST; Wollowitz S; Corash L
    Transfusion; 1997 Apr; 37(4):423-35. PubMed ID: 9111281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates.
    Taha M; Culibrk B; Kalab M; Schubert P; Yi QL; Goodrich R; Ramirez-Arcos S
    Vox Sang; 2017 Jul; 112(5):408-416. PubMed ID: 28378343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
    Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
    Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Yi Q; Thiele T; Greinacher A; Marschner S; Devine DV
    Transfusion; 2017 Aug; 57(8):2026-2034. PubMed ID: 28500654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.